Cognition Therapeutics, Inc. (CGTX) Tops Q3 EPS by 4c
Tweet
Share
E-mailGet Alerts CGTX Hot Sheet
Join SI Premium – FREE
Cognition Therapeutics, Inc. (NASDAQ: CGTX) reported Q3 EPS of ($0.06), $0.04 better than the analyst estimate of ($0.10).
For earnings history and earnings-related data on Cognition Therapeutics, Inc. (CGTX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA maintains underperform ratings on six BDC stocks
- Myriad Uranium completes acquisition of Rush Rare Metals
- Boeing workers reject contract, authorize strike
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
